The bulky N6 substituent of cabergoline is responsible for agonism of this drug at 5-hydroxytryptamine 5-HT2A and 5-HT2B receptors and thus is a determinant of valvular heart disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples